Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Molecular Inflammation Board at the Centers for Personalized Medicine at the University Hospitals of Freiburg, Heidelberg, Tübingen and Ulm - A Multicenter Prospective Observational Study

NCT07132333 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT07132333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Molecular Inflammation Board at the Centers for Personalized Medicine at the University Hospitals of Freiburg, Heidelberg, Tübingen and Ulm - A Multicenter Prospective Observational Study
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Recruiting
Start date
November 16, 2022
Completion date
November 30, 2032
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease (crohn's disease and ulcerative colitis), psoriasis (pso), psoriasis arthritis, spondylarthropathies